⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)

Official Title: A Phase 1b/2 Study of Entospletinib (GS-9973) Monotherapy and in Combination With Chemotherapy in Patients With Acute Myeloid Leukemia (AML)

Study ID: NCT02343939

Study Description

Brief Summary: This study will evaluate the efficacy, safety, and tolerability of entospletinib when administered as monotherapy or in combination with chemotherapy in adults with acute myeloid leukemia (AML).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

UCLA, Los Angeles, California, United States

University of Chicago, Chicago, Illinois, United States

Loyola University Medical Center, Maywood, Illinois, United States

Indiana University, Indianapolis, Indiana, United States

University of Kansas Medical Center Research Institute, Inc, Fairway, Kansas, United States

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Henry Ford Health System, Detroit, Michigan, United States

Karmanos Cancer Institute, Detroit, Michigan, United States

Weill Cornell Medical College - New York - Presbyterian Hospital, New York, New York, United States

Duke Cancer Center, Durham, North Carolina, United States

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Ohio State University, Columbus, Ohio, United States

Oregon Health & Science University, Portland, Oregon, United States

Saint Francis Cancer Center, Greenville, South Carolina, United States

Princess Margaret, Toronto, Ontario, Canada

Jewish General Hospital, Montreal, Quebec, Canada

Universitätsklinikum Frankfurt Medizinische Klinik II, Frankfurt, , Germany

Contact Details

Name: Gilead Study Director

Affiliation: Gilead Sciences

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: